Exploratory PK/ PD IV study for MR30365/07

• Research type

  Research Study

• Full title

  A double-blind, placebo-controlled, dose-ascending study in healthy subjects to assess the safety, tolerability and pharmacokinetic/ pharmacodynamic profile of MR30365/07 given as an 8-hour infusion with and without naltrexone.

• IRAS ID

  128741

• Contact name

  Jo Collier

• Contact email

  jo.collier@quotientbioresearch.com

• Sponsor organisation

  Mundipharma Research Ltd.

• Eudract number

  2012-001558-24

• ISRCTN Number

  to be registered

• REC name

  Wales REC 1

• REC reference

  13/WA/0082

• Date of REC Opinion

  14 Apr 2013

• REC opinion

  Favourable Opinion